Arrowpoint Investment Partners »

Capricor Therapeutics shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Capricor Therapeutics (CAPR) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Capricor Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Capricor Therapeutics held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Capricor Therapeutics by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $225k 9.3k 24.08

More positions owned by Arrowpoint Investment Partners

Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Citigroup Com New (C)
Goldman Sachs (GS)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Global Payments (GPN)
Norfolk Southern (NSC)
American Electric Power Company (AEP)
NVIDIA Corporation (NVDA)
Exxon Mobil Corporation (XOM)
Ishares Msci Sth Kor Etf Put Option (EWY)
Ishares Msci Taiwan Etf (EWT)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology (MU)
Ishares Tr Expanded Tech Call Option (IGV)
Intel Corporation (INTC)

View all positions for Arrowpoint Investment Partners

Top funds holding Capricor Therapeutics

BlackRock
Tang Capital Management
Suvretta Capital Management
Vanguard Capital Management
State Street Corporation
Susquehanna International
Goldman Sachs Group
Citadel Advisors
RA Capital Management
Perceptive Advisors
Boxer Capital Management
Geode Capital Management
FMR
Diadema Partners
Ikarian Capital

View all funds holding Capricor Therapeutics